Daily Health Headlines

Cancer Treatment More Likely to Leave Blacks in Debt

👤by Mary Elizabeth Dallas 0 comments 🕔Tuesday, September 27th, 2016

MONDAY, Sept. 26, 2016 (HealthDay News) -- Black cancer survivors are more likely than whites to wind up in debt or forego treatment due to cost, a new study finds.

"More than 1.6 million adults are diagnosed with cancer in the United States each year, and many face some form of financial hardship related to cancer and cancer treatment, even when they're insured," said study author Theresa Hastert.

Hastert is an assistant professor in the department of oncology at Wayne State University School of Medicine and the Barbara Ann Karmanos Cancer Institute, in Detroit.

"In order to pay for cancer care, many patients experience changes to their financial situation that can include everything from cutting back on leisure spending to dipping into savings or selling assets, taking on debt, or even losing a home or declaring bankruptcy," Hastert said.

Researchers looked at these strains and their effect on people of different races. They focused on 1,000 cancer survivors between the ages of 20 and 79 who were diagnosed and/or treated at Karmanos. All had survived an initial diagnosis of breast, colon, lung or prostate cancer. They answered questions about the financial impact of their treatment and their socioeconomic status.

So far, 695 people have participated in the study, including 414 black survivors. Overall, about 52 percent of the participants were facing some type of financial stress related to their treatment. That included that about 57 percent of blacks and 47 percent of whites.

The study revealed that 31 percent of the black patients went into debt for their treatment, compared to 18 percent of whites.

Black cancer survivors were also more likely to have made some treatment decisions based on cost concerns, such as avoiding an office visit or skipping doses of prescribed medicines. Such cost-cutting moves were made by 21 percent of black survivors, compared to about 15 percent of whites.

Slightly more white patients than blacks -- 25 percent vs. 19 percent -- tapped savings, retirement accounts and other assets to pay for their care.

The researchers said differences in net worth, job status and insurance may have contributed to the added financial burden for black patients.

"Being African-American does not 'cause' the observed differences in financial hardship, but being black in the United States is associated with several conditions that all contribute to differences in socioeconomic status and to differences in the types of financial hardship experienced as a result of cancer, in the existence of lasting debt, and to not accessing necessary care because of cost," Hastert said.

She made her comments in an American Association for Cancer Research (AACR) news release

The findings were to be presented Sunday at an AACR meeting in Fort Lauderdale, Fla.

Studies presented at medical meetings are considered preliminary because they are not subject to the same scrutiny as those in peer-reviewed journals.

-- Mary Elizabeth Dallas

Article Credits / Source

Mary Elizabeth Dallas / HealthDay

Mary Elizabeth Dallas wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: American Association for Cancer Research, news release, Sept. 25, 2016.

View More Articles From Mary Elizabeth Dallas 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!